5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
Primary endpoint(s) modified
Also in this update: Enrollment increased: 5000 → 10000 participants; Interventions modified
Yonsei UniversityNot specified NCT02038127 Registry history of NCT02038127 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 65 participants (planned 87)
Yonsei UniversityPhase 2 NCT05786430 Registry history of NCT05786430 on ClinicalTrials.gov (opens the registry)
Updated
Completed without a posted recruiting period
Yonsei UniversityNot applicable NCT06976580 Registry history of NCT06976580 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
Yonsei UniversityPhase 2 NCT06537076 Registry history of NCT06537076 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Dec 2022); last known: Recruiting
Yonsei UniversityPhase 2 NCT05679583 Registry history of NCT05679583 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-13 | NCT07871604 Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With… | Phase 4 | Not Yet Recruiting |
| 2026-10-09 | NCT07869602 Efficacy and Safety of the Angionix Balloon in Patients With Coronary Artery Disease… | Not Yet Recruiting | |
| 2026-09-29 | NCT07845877 An Intervention to Reduce Sedentary Behavior and Promote Physical Activity in Colorectal… | Not Yet Recruiting | |
| 2026-09-28 | NCT07843901 Lenvatinib in Patients With Advanced Parathyroid Carcinoma | Phase 2 | Not Yet Recruiting |
| 2026-09-17 | NCT07824414 Prognostic Value of Pulse Oximetry Differences | Recruiting |
| Phase 1 | 3 | |
| Phase 1/2 | 8 | |
| Phase 2 | 32 | |
| Phase 3 | 3 | |
| Phase 4 | 26 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT06528262 | Effect of Enavogliflozin on Recurrence of Atrial Fibrillation After Catheter Ablation | Atrial Fibrillation | Recruiting | 2026-05-12 |
| NCT07471867 | Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry… | Chronic Coronary Syndrome | Recruiting | 2026-04-24 |
| NCT03770312 | Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in… | Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease | Recruiting | 2025-11-18 |
| NCT07147491 | Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait… | Hip Surgery | Recruiting | 2025-08-29 |
| NCT07147530 | Effectiveness and Safety of the Electrically Powered Orthopedic Exercise Device on Gait… | Hip Disease | Recruiting | 2025-08-29 |
| NCT07147543 | Effectiveness and Safety of Electrically Powered Orthopedic Exercise Device for Gait… | Gait Disorders | Recruiting | 2025-08-29 |
| NCT06897176 | Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke… | Stroke | Recruiting | 2025-03-26 |
| NCT06878482 | Effect of Blood Flow by Botulinum Toxin Injection for Severe Peripheral Artery Occlusive… | Chronic Ulcer of Lower Extremity | Recruiting | 2025-03-17 |
| NCT03059069 | The Effect of Gliatamin (Chonline Alphoscerate) on Depressive Mood in Type 2 Diabetes… | Type2 Diabetes With Depressive Mood | Recruiting | 2025-02-24 |
| NCT06784557 | Effect of Ezetimibe on Gut Microbiota | Atherosclerotic Cardiovascular Disease With Dyslipidemia | Recruiting | 2025-01-20 |
| NCT06543758 | Effectiveness and Safety of At-home Gait Rehabilitation Using Wearable Exoskeletal Robot | Stroke | Recruiting | 2024-11-19 |
| NCT06580717 | ENavogliflozin DElivering Alleviation of Ventricular Diastolic Dysfunction in… | Nonobstructive Hypertrophic Cardiomyopathy | Recruiting | 2024-11-08 |
| NCT06642623 | A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes… | Diabetes Mellitus, Type 2 | Recruiting | 2024-10-15 |
| NCT04432220 | AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial… | Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation | Recruiting | 2023-02-06 |
| NCT07871604 | Feasibility of Combination Therapy With Low-dose Statin and Ezetimibe in Patients With… | Atherosclerosis Cardiovascular Disease | Not Yet Recruiting | 2026-10-13 |
| NCT07814144 | Venous Closure System After AF Ablation | Atrial Fibrillation | Active, Not Recruiting | 2026-09-10 |
| NCT07687394 | A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical… | Stomach Neoplasms | Not Yet Recruiting | 2026-07-07 |
| NCT05361421 | Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular… | Cardiovascular Disease | Active, Not Recruiting | 2026-05-29 |
| NCT07467174 | RCT Comparing Reduced-port Robotic and Conventional Laparoscopic Subtotal Gastrectomy | Gastric Cancer | Not Yet Recruiting | 2026-03-12 |
| NCT07265128 | Remimazolam vs Midazolam to Reduce Delirium in Adults ≥65 Undergoing CPB Valve Surgery | Delirium | Not Yet Recruiting | 2025-12-04 |
| NCT05910476 | Comparative Study of Rosuvastatin/Ezetimib 20/10 mg and Atovastatin/Ezetimib 40/10 mg… | Coronary Artery Disease | Active, Not Recruiting | 2025-11-25 |
| NCT07238972 | Postoperative Intravenous Ferric Derisomaltose for Prevention of Long-term Anemia After… | Anemia | Not Yet Recruiting | 2025-11-20 |
| NCT07237308 | BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial… | Stroke | Not Yet Recruiting | 2025-11-19 |
| NCT07108985 | Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4… | Diabetes Mellitus, Type 2 | Not Yet Recruiting | 2025-08-07 |
| NCT03947229 | A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet… | Coronary Artery Disease | Active, Not Recruiting | 2024-10-24 |
Heart Disease (66) · Atrial Fibrillation (21) · Coronary Artery Disease (19) · Lung Cancer (11) · Stroke (11) · Gastric Cancer (9) · Heart Failure (8) · Non-Small Cell Lung Cancer (NSCLC) (7) · Breast Cancer (6) · Diabetes (5)